1. Home
  2. Pharma & Healthcare
  3. Global Viral Vectors in Gene Therapy Market Status and Forecast 2021-2027

Global Viral Vectors in Gene Therapy Market Status and Forecast 2021-2027

Publication Month: Sep 2021 | No. of Pages: 129 Published By: GRD Survey
Single User License: US $ 2980
Corporate User License: US $ 5960

This report provides a comprehensive analysis of current global Viral Vectors in Gene Therapy market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Viral Vectors in Gene Therapy industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to this survey, the global Viral Vectors in Gene Therapy market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Viral Vectors in Gene Therapy Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Viral Vectors in Gene Therapy market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Viral Vectors in Gene Therapy Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Viral Vectors in Gene Therapy industry.
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
Integrating Viral Vectors
Non-Integrating Viral Vectors

Segmented by Application
Metabolic Diseases
Cardiovascular Diseases
Muscular Diseases
Hematologic Diseases
Ophthalmologic Diseases
Infectious Diseases
Others

Segmented by Country
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australasia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
Israel
Turkey
South Africa
Saudi Arabia

Key manufacturers included in this survey
Spark Therapeutics
SIBIONO
Shanghai Sunway Biotech
Sarepta Therapeutics
Orchard Therapeutics
Novartis
Lonza
Ionis Pharmaceuticals
Gilead Sciences
Catalent
Biogen
AnGes
Amgen


Table of Contents

1 Product Introduction and Overview
1.1 Product Definition
1.2 Product Specification
1.3 Global Market Overview
1.3.1 Global Viral Vectors in Gene Therapy Market Status and Forecast (2016-2027)
1.3.2 Global Viral Vectors in Gene Therapy Sales Value CAGR by Region
1.4 Market Drivers, Inhibitors
1.4.1 Market Drivers
1.4.2 Market Inhibitors
1.4.3 COVID-19 Impact Analysis
2 Global Viral Vectors in Gene Therapy Supply by Company
2.1 Global Viral Vectors in Gene Therapy Sales Value by Company
2.2 Viral Vectors in Gene Therapy Sales Area of Main Manufacturers
2.3 Trend of Concentration Rate
3 Global and Regional Viral Vectors in Gene Therapy Market Status by Type
3.1 Viral Vectors in Gene Therapy Type Introduction
3.1.1 Integrating Viral Vectors
3.1.2 Non-Integrating Viral Vectors
3.2 Global Viral Vectors in Gene Therapy Market by Type
3.3 North America: by Type
3.4 Europe: by Type
3.5 Asia Pacific: by Type
3.6 Central & South America: by Type
3.7 Middle East & Africa: by Type
4 Global and Regional Viral Vectors in Gene Therapy Market Status by Application
4.1 Viral Vectors in Gene Therapy Segment by Application
4.1.1 Metabolic Diseases
4.1.2 Cardiovascular Diseases
4.1.3 Muscular Diseases
4.1.4 Hematologic Diseases
4.1.5 Ophthalmologic Diseases
4.1.6 Infectious Diseases
4.1.7 Others
4.2 Global Viral Vectors in Gene Therapy Market by Application
4.3 North America: by Application
4.4 Europe: by Application
4.5 Asia Pacific: by Application
4.6 Central & South America: by Application
4.7 Middle East & Africa: by Application
5 Global Viral Vectors in Gene Therapy Market Status by Region
5.1 Global Viral Vectors in Gene Therapy Market by Region
5.2 North America Viral Vectors in Gene Therapy Market Status
5.3 Europe Viral Vectors in Gene Therapy Market Status
5.4 Asia Pacific Viral Vectors in Gene Therapy Market Status
5.5 Central & South America Viral Vectors in Gene Therapy Market Status
5.6 Middle East & Africa Viral Vectors in Gene Therapy Market Status
6 North America Viral Vectors in Gene Therapy Market Status
6.1 North America Viral Vectors in Gene Therapy Market by Country
6.2 United States
6.3 Canada
6.4 Mexico
7 Europe Viral Vectors in Gene Therapy Market Status
7.1 Europe Viral Vectors in Gene Therapy Market by Country
7.2 Germany
7.3 France
7.4 UK
7.5 Italy
7.6 Russia
7.7 Spain
8 Asia Pacific Viral Vectors in Gene Therapy Market Status
8.1 Asia Pacific Viral Vectors in Gene Therapy Market by Country
8.2 China
8.3 Japan
8.4 Korea
8.5 Southeast Asia
8.6 India
8.7 Australasia
9 Central & South America Viral Vectors in Gene Therapy Market Status
9.1 Central & South America Viral Vectors in Gene Therapy Market by Country
9.2 Brazil
9.3 Argentina
9.4 Colombia
10 Middle East & Africa Viral Vectors in Gene Therapy Market Status
10.1 Middle East & Africa Viral Vectors in Gene Therapy Market by Country
10.2 Iran
10.3 Israel
10.4 Turkey
10.5 South Africa
10.8 Saudi Arabia
11 Major Downstream Customers Analysis
11.1 Customer One Analysis
11.2 Customer Two Analysis
11.3 Customer Three Analysis
11.4 Customer Four Analysis
12 Global Viral Vectors in Gene Therapy Market Forecast by Type and by Application
12.1 Global Viral Vectors in Gene Therapy Sales Value Forecast (2022-2027)
12.2 Global Viral Vectors in Gene Therapy Forecast by Type
12.3 Global Viral Vectors in Gene Therapy Forecast by Application
13 Global Viral Vectors in Gene Therapy Market Forecast by Region/Country
13.1 Global Viral Vectors in Gene Therapy Market Forecast by Region (2022-2027)
13.2 North America Market Forecast
13.3 Europe Market Forecast
13.4 Asia Pacific Market Forecast
13.5 Central & South America Market Forecast
13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
14.1 Spark Therapeutics
14.1.1 Company Information
14.1.2 Viral Vectors in Gene Therapy Product Introduction
14.1.3 Spark Therapeutics Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.1.4 SWOT Analysis
14.2 SIBIONO
14.2.1 Company Information
14.2.2 Viral Vectors in Gene Therapy Product Introduction
14.2.3 SIBIONO Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.2.4 SWOT Analysis
14.3 Shanghai Sunway Biotech
14.3.1 Company Information
14.3.2 Viral Vectors in Gene Therapy Product Introduction
14.3.3 Shanghai Sunway Biotech Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.3.4 SWOT Analysis
14.4 Sarepta Therapeutics
14.4.1 Company Information
14.4.2 Viral Vectors in Gene Therapy Product Introduction
14.4.3 Sarepta Therapeutics Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.4.4 SWOT Analysis
14.5 Orchard Therapeutics
14.5.1 Company Information
14.5.2 Viral Vectors in Gene Therapy Product Introduction
14.5.3 Orchard Therapeutics Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.5.4 SWOT Analysis
14.6 Novartis
14.6.1 Company Information
14.6.2 Viral Vectors in Gene Therapy Product Introduction
14.6.3 Novartis Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.6.4 SWOT Analysis
14.7 Lonza
14.7.1 Company Information
14.7.2 Viral Vectors in Gene Therapy Product Introduction
14.7.3 Lonza Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.7.4 SWOT Analysis
14.8 Ionis Pharmaceuticals
14.8.1 Company Information
14.8.2 Viral Vectors in Gene Therapy Product Introduction
14.8.3 Ionis Pharmaceuticals Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.8.4 SWOT Analysis
14.9 Gilead Sciences
14.9.1 Company Information
14.9.2 Viral Vectors in Gene Therapy Product Introduction
14.9.3 Gilead Sciences Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.9.4 SWOT Analysis
14.10 Catalent
14.10.1 Company Information
14.10.2 Viral Vectors in Gene Therapy Product Introduction
14.10.3 Catalent Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
14.10.4 SWOT Analysis
14.11 Biogen
14.12 AnGes
14.13 Amgen
15 Conclusion
16 Methodology

Tables and Figures

List of Tables

Table Global Viral Vectors in Gene Therapy Sales Value (Million USD) and CAGR by Region (2016-2027)
Table Global Viral Vectors in Gene Therapy Sales Value (Million USD) by Company (2019-2021)
Table Global Viral Vectors in Gene Therapy Sales Value Market Share by Company (2019-2021)
Table Main Manufacturers Viral Vectors in Gene Therapy Sales Area
Table Viral Vectors in Gene Therapy Market Concentration (Top 3, Top 5) (2019-2021)
Table Global Viral Vectors in Gene Therapy Sales Value (Million USD) by Type (2016-2021)
Table Global Viral Vectors in Gene Therapy Sals Value Market Share by Type (2016-2021)
Table North America Viral Vectors in Gene Therapy Sales Value (Million USD) by Type (2016-2021)
Table North America Viral Vectors in Gene Therapy Sales Value Market Share by Type (2016-2021)
Table Europe Viral Vectors in Gene Therapy Sales Value (Million USD) by Type (2016-2021)
Table Europe Viral Vectors in Gene Therapy Sales Value Market Share by Type (2016-2021)
Table Asia Pacific Viral Vectors in Gene Therapy Sales Value (Million USD) by Type (2016-2021)
Table Asia Pacific Viral Vectors in Gene Therapy Sales Value Market Share by Type (2016-2021)
Table Central & South America Viral Vectors in Gene Therapy Sales Value (Million USD) by Type (2016-2021)
Table Central & South America Pacific Viral Vectors in Gene Therapy Sales Value Market Share by Type (2016-2021)
Table Middle East & Africa Viral Vectors in Gene Therapy Sales Value (Million USD) by Type (2016-2021)
Table Middle East & Africa Viral Vectors in Gene Therapy Sales Value Market Share by Type (2016-2021)
Table Global Viral Vectors in Gene Therapy Sales Value (Million USD) by Application (2016-2021)
Table Global Viral Vectors in Gene Therapy Value Market Share by Application (2016-2021)
Table North America Viral Vectors in Gene Therapy Sales Value (Million USD) by Application (2016-2021)
Table North America Viral Vectors in Gene Therapy Sales Value Market Share by Application (2016-2021)
Table Europe Viral Vectors in Gene Therapy Sales Value (Million USD) by Application (2016-2021)
Table Europe Viral Vectors in Gene Therapy Sales Value Market Share by Application (2016-2021)
Table Asia Pacific Viral Vectors in Gene Therapy Sales Value (Million USD) by Application (2016-2021)
Table Asia Pacific Viral Vectors in Gene Therapy Sales Value Market Share by Application (2016-2021)
Table Central & South America Viral Vectors in Gene Therapy Sales Value (Million USD) by Application (2016-2021)
Table Central & South America Pacific Viral Vectors in Gene Therapy Sales Value Market Share by Application (2016-2021)
Table Middle East & Africa Viral Vectors in Gene Therapy Sales Value (Million USD) by Application (2016-2021)
Table Middle East & Africa Viral Vectors in Gene Therapy Sales Value Market Share by Application (2016-2021)
Table Global Viral Vectors in Gene Therapy Sales Value (Million USD) by Region (2016-2021)
Table Global Viral Vectors in Gene Therapy Value Market Share by Region (2016-2021)
Table North America Viral Vectors in Gene Therapy Sales Value (Million USD) by Country (2016-2021)
Table North America Viral Vectors in Gene Therapy Value Market Share by Country (2016-2021)
Table Europe Viral Vectors in Gene Therapy Sales Value (Million USD) by Country (2016-2021)
Table Europe Viral Vectors in Gene Therapy Value Market Share by Country (2016-2021)
Table Asia Pacific Viral Vectors in Gene Therapy Sales Value (Million USD) by Country (2016-2021)
Table Asia Pacific Viral Vectors in Gene Therapy Value Market Share by Country (2016-2021)
Table Central & South America Viral Vectors in Gene Therapy Sales Value (Million USD) by Country (2016-2021)
Table Central & South America Viral Vectors in Gene Therapy Value Market Share by Country (2016-2021)
Table Middle East & Africa Viral Vectors in Gene Therapy Sales Value (Million USD) by Country (2016-2021)
Table Middle East & Africa Viral Vectors in Gene Therapy Value Market Share by Country (2016-2021)
Table Global Viral Vectors in Gene Therapy Value (Million USD) Forecast by Type (2022-2027)
Table Global Viral Vectors in Gene Therapy Value Market Share Forecast by Type (2022-2027)
Table Global Viral Vectors in Gene Therapy Value (Million USD) Forecast by Application (2022-2027)
Table Global Viral Vectors in Gene Therapy Value Market Share Forecast by Application (2022-2027)
Table Global Viral Vectors in Gene Therapy Value (Million USD) Forecast by Region (2022-2027)
Table Global Viral Vectors in Gene Therapy Value Market Share Forecast by Region (2022-2027)
Table Spark Therapeutics Company Information
Table Spark Therapeutics Product Introduction
Table Spark Therapeutics Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table SIBIONO Company Information
Table SIBIONO Product Introduction
Table SIBIONO Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Shanghai Sunway Biotech Company Information
Table Shanghai Sunway Biotech Product Introduction
Table Shanghai Sunway Biotech Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Sarepta Therapeutics Company Information
Table Sarepta Therapeutics Product Introduction
Table Sarepta Therapeutics Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Orchard Therapeutics Company Information
Table Orchard Therapeutics Product Introduction
Table Orchard Therapeutics Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Novartis Company Information
Table Novartis Product Introduction
Table Novartis Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Lonza Company Information
Table Lonza Product Introduction
Table Lonza Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Ionis Pharmaceuticals Company Information
Table Ionis Pharmaceuticals Product Introduction
Table Ionis Pharmaceuticals Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Gilead Sciences Company Information
Table Gilead Sciences Product Introduction
Table Gilead Sciences Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)
Table Catalent Company Information
Table Catalent Product Introduction
Table Catalent Viral Vectors in Gene Therapy Sales Value, Gross Margin and Global Share (2019-2021)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets